Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Tuszyn

8 clinical trials in Tuszyn, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Tuszyn at a glance
8
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

8 trials in Tuszyn

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Alcoholism

Recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Oxybate
  • Sponsor:Laboratorio Farmaceutico C.T. S.r.l.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Seaport Therapeutics Inc.
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:(1S)-1-[4-[3-[4-(6-FLUORO-1,2-BENZOXAZOL-3-YL)PIPERIDIN-1-YL]PROPOXY]-3-METHOXYPHENYL]ETHANOL
  • Sponsor:Vanda Pharmaceuticals Netherlands B.V.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Beckley Psytech Limited

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Tuszyn

What the registry says about research in the country

01 Mental Health Research

Groundbreaking studies focusing on Major Depressive Disorder (MDD) are evaluating new therapeutic approaches. These trials explore innovative treatments using novel compounds to address persistent depressive symptoms.

  • Depression Treatment Studies
  • Long-term Safety Assessments
  • Novel Therapeutic Approaches

Special attention is being given to the development of kappa opioid receptor antagonists for depression management.

02 Treatment-Resistant Conditions

Innovative research targeting Treatment-Resistant Depression through intranasal delivery systems. These studies combine medication with psychological support to enhance treatment outcomes.

  • Intranasal Therapeutics
  • Combined Treatment Approaches
  • Safety Monitoring

Researchers are exploring both immediate and long-term effectiveness of these novel treatment methods.

03 Addiction Medicine

Critical research into alcohol dependence treatments, focusing on reducing consumption patterns and maintaining abstinence in high-risk individuals.

  • Alcohol Consumption Reduction
  • Risk Level Assessment
  • Therapeutic Interventions

Studies evaluate the efficacy of Sodium Oxybate in treating severe alcohol dependency cases.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.